RecruitingNCT06705036

Differential Study of Invasive Pituitary Adenomas in the Sellar and Cavernous Sinus Regions


Sponsor

Shanghai Zhongshan Hospital

Enrollment

20 participants

Start Date

Nov 1, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

This study involves collecting paired tumor samples from intrasellar and cavernous sinus regions of 20 invasive pituitary tumor patients, preserving them at -80°C for quality multi-omics analysis. Proteomics and transcriptomics are employed to identify molecular differences, while imaging data (MRI/CT) assesses tumor morphology and invasion. In vitro experiments and mechanistic studies validate key findings, exploring how regional molecular differences affect tumor behavior. Data integration combines multi-omics and imaging features to uncover biomarkers and pathways associated with invasiveness and regional specificity, with statistical analysis ensuring significance and reliability.


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Inclusion Criteria4

  • Invasive pituitary tumors involving the cavernous sinus
  • Retrospective inclusion of patients who have signed informed consent forms for the donation of biological samples and health-related information
  • Age range: 18-80 years
  • Subjects are willing to participate in this study

Exclusion Criteria3

  • Non-invasive pituitary tumors
  • Pregnant or breastfeeding
  • Other conditions deemed unsuitable for participation in this clinical trial as assessed by the physician

Interventions

OTHERsurgery

Samples were obtained from patients by surgical excision and matched into groups


Locations(1)

Zhongshan Hospital Fudan University

Shanghai, Shanghai Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06705036


Related Trials